Where you prescribed Xarelto for artrial fibrillation?
Xarelto Bleeding Lawsuits
Xarelto, an anticoagulant blood thinner approved by the FDA in 2011, is prescribed to reduce the risks of stroke and blood clots in individuals suffering from atrial fibrillation, also known as A-Fib. Similar to other blood thinners such as Coumadin and Pradaxa, the drug reduces the chance of blood clots forming and traveling to the brain, which result in stroke or embolism, and blocked arteries.
Last May, a suit was filed in Pennsylvania on behalf of a woman who died after taking Xarelto. The Xarelto bleeding lawsuit states that Bayer and Janssen Pharmaceuticals, a Johnson and Johnson subsidiary, “fervently marketed” Xarelto without regard for reports of 356 serious, disabling and fatal injuries involving major bleeding, hemorrhaging and death. A Florida woman also filed suit after her husband died after taking Xarelto to treat A-Fib. Further, the drug is suspected of causing 72 deaths in the first quarter of 2013 in Germany alone.
FDA Issues Serious Warnings
The FDA has issued two black box (the strictest) warnings on Xarelto:
- People with A-Fib, not caused by a heart valve problem, who discontinue Xarelto without replacing it with another blood thinner are at risk for dangerous blood clots
- A spinal anesthesia performed on a person taking Xarelto may result in bleeding around the spine that can lead to long-term or permanent paralysis.
Nager, Romaine & Schneiberg is here to advocate on your behalf. If you or a loved one has experienced life-threatening and related side effects following the use of Xarelto, you may be entitled to compensation. These may include:
- Heart attack
- Gastrointestinal bleeding
- Blood Clots
We will evaluate the feasibility of a lawsuit and help determine whether you are entitled to compensation. Call us at 216-289-4740, or toll-free at (855) GOT-HURT.